Life-threatening organ dysfunction triggered by infection.
1
Conclusion: Health care-associated sepsis and pneumonia impose substantial clinical and economic costs.
2
Background: Timely identification and treatment of sepsis is crucial for patient outcome.
3
Prevention of E coli sepsis, especially among preterm infants, remains a challenge.
4
Thus, inhibition of miR-195 may represent a new therapeutic approach for sepsis.
5
Two matched referents free of known sepsis were selected for each case.
6
However, it is able to improve long-term cognitive impairment in sepsis survivors.
7
Conclusions: PF caused a significant attenuation of the acute-phase response in sepsis.
8
New therapeutic strategies for sepsis try to establish a well-balanced immune response.
9
Method: A review of the current understanding of sepsis definitions in burns.
10
Mortality caused by sepsis was higher among diabetic patients across all populations.
11
Setting: Critical care randomised control trials in severe sepsis and septic shock.
12
We included adult patients with severe sepsis based on the sepsis-2 criteria.
13
The mortality rate of severe sepsis and septic shock remains still high.
14
Recent studies have shown that increased lymphocyte apoptosis contributes to sepsis-induced mortality.
15
Objectives: Excessive inflammation is closely related to severity and outcome of sepsis.
16
Introduction: The management of sepsis includes the prompt administration of intravenous antibiotics.
